Share on StockTwits

Athersys (NASDAQ:ATHX) Director Lorin Randall sold 15,000 shares of the stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $1.54, for a total transaction of $23,100.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Athersys (NASDAQ:ATHX) traded down 1.32% on Tuesday, hitting $1.50. The stock had a trading volume of 395,529 shares. Athersys has a 52 week low of $1.08 and a 52 week high of $4.33. The stock’s 50-day moving average is $1.63 and its 200-day moving average is $2.37. The company’s market cap is $115.6 million.

Athersys (NASDAQ:ATHX) last released its earnings data on Monday, August 11th. The company reported $0.01 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.09) by $0.10. The company had revenue of $0.40 million for the quarter, compared to the consensus estimate of $0.70 million. The company’s quarterly revenue was down 33.3% on a year-over-year basis. On average, analysts predict that Athersys will post $-0.33 earnings per share for the current fiscal year.

Athersys, Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.